CHEMTIDE Trademark

Trademark Overview

On Friday, June 5, 2020, a trademark application was filed for CHEMTIDE with the United States Patent and Trademark Office. The USPTO has given the CHEMTIDE trademark a serial number of 88951164. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 29, 2021. This trademark is owned by Sotira, LLC. The CHEMTIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment and prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical preparations for SARS-CoV2 or COVID-19; Pharmaceutical preparations, namely, elixirs for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Chemical preparations for pharmaceutical or medical purposes, namely, for SARS-CoV2 or COVID-19; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
chemtide

General Information

Serial Number88951164
Word MarkCHEMTIDE
Filing DateFriday, June 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 29, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment and prevention of SARS-CoV2 or COVID-19; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical preparations for SARS-CoV2 or COVID-19; Pharmaceutical preparations, namely, elixirs for the treatment of SARS-CoV2 or COVID-19; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Chemical preparations for pharmaceutical or medical purposes, namely, for SARS-CoV2 or COVID-19; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSotira, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPhoenix, AZ 85016
Party NameSotira, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPhoenix, AZ 85016

Trademark Events

Event DateEvent Description
Monday, November 29, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 29, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 19, 2021ASSIGNED TO EXAMINER
Monday, June 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 9, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

chemtide pharmaceutical preparations sars covid treatment diseases respiratory disorders prevention treating